Bayesian Capital Management, LP

Position in BMY — Bristol Myers Squibb Co

CIK 1632551 Brooklyn, NY

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,106,304

-$43,746 QoQ

Shares Held

19,200

-24.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#1,114

of 2,514 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bayesian Capital Management, LP holds $5,153,335 across 7 Drug Manufacturers - General names. BMY ranks #2 (21.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	9,100	$1,149,694
2	BMY	Bristol Myers Squibb Co This page	19,200	$1,106,304
3	GSK	GSK plc	18,100	$948,802
4	AMGN	Amgen Inc	2,384	$863,294
5	NVO	Novo Nordisk A S	8,500	$407,490
6	NVS	Novartis AG	2,365	$370,642
7	SNY	Sanofi	7,199	$307,109

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,106,304	19,200	-24.7%	Shares	Sole	2026-08-14
2025-09-30	$1,150,050	25,500	+483.1%	Shares	Sole	2025-11-14
2025-06-30	$202,426	4,373	-76.0%	Shares	Sole	2025-08-14
2024-09-30	$941,668	18,200	+52.9%	Shares	Sole	2024-11-14
2024-06-30	$494,207	11,900	-88.6%	Shares	Sole	2024-08-14
2023-12-31	$5,377,288	104,800	+495.6%	Shares	Sole	2024-02-14
2021-09-30	$1,041,214	17,597	+26.4%	Shares	Sole	2021-11-15
2021-06-30	$930,134	13,920	-76.1%	Shares	Sole	2021-08-13
2021-03-31	$3,673,534	58,190	+9.0%	Shares	Sole	2021-05-14
2020-12-31	$3,312,402	53,400	+190.2%	Shares	Sole	2021-02-12
2020-09-30	$1,109,336	18,400	-23.3%	Shares	Sole	2020-11-12
2020-06-30	$1,411,200	24,000	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.